For the collaborative ecosystem that was established during the pandemic, India must adopt a methodical strategy. For India to become a medical devices manufacturing hub, everything...
With the advent of automation, IoT, AI, and ML, hematology analyzers are poised for major upgrades. Healthcare professionals would receive reports and updates promptly on a...
The need for sophisticated integrated system urges the research and development of CLIA systems, which are able to integrate with other modules and have a larger...
“By 2050, the ways in which we watch our health, seek medical advice, get treatment, and what we’re treated for will change dramatically. While it is...
The advantage of automation is that instruments are more powerful, can aggregate data more quickly, and can find analytical insights that otherwise would not be found...
Demand for automated clinical chemistry analyzers is growing as laboratories work to improve operational efficiency and lower total cost of ownership. Global healthcare solutions are continually...
In the coming years, advances in microfluidics, POC platforms, novel biosensors, lab-on-a-chip, new wash-free immunoassay formats, and smart technologies will lead to much enhanced multiplex immunoassays....
With point-of-care testing on the rise, PoC hematology analyzers are expected to grow at a rapid pace compared to standalone devices in coming years. Many analytes...
While robots may not be coming for the biochemist’s job just yet, it may be a different matter once automation is coupled with advanced AI. One...
Although the immunoassay field has mature segments, companies continue to develop immunoassays and immunoassay instrument platforms to improve assay sensitivity. Be it for determining a Vitamin-D...
New tools and parameters will continue to emerge as market competition increases, and technology evolves. These are exciting times, and the next five years promise to...
Advances in genetic knowledge are creating new markets for immunoassay, while traditional immunoassay maintains a strong position in the growing market for clinical diagnostics. The workhorse...
As the need for COVID-19 testing collapses to a fraction of its current demand, molecular diagnostics companies will be holding and maintaining facilities that can create...
Once COVID-19 peters out, demand for D-dimer test shall also peter out, yet the market size is expected to have stabilized at double the market from...
Automation is a key technological advancement, affecting the efficiency and accuracy delivered by the next-gen urinalysis devices, and hence, the persistent demand for novel urinalysis instruments....
Copyright © 2024 Medical Buyer